Vermillion (VRML) Tops Q3 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. WCN
7. SPOT
8. SPY
9. FIX
10. TSCO

Go back to Vermillion (VRML) Tops Q3 EPS by 1c

Vermillion Reports Third Quarter 2015 Financial Results and Business Update

November 12, 2015 8:01 AM EST

AUSTIN, Texas, Nov. 12, 2015 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a bio-analytical solutions company focused on gynecologic disease, reported financial results for the third quarter ended September 30, 2015 and provided a business update.

Valerie Palmieri, President and CEO of Vermillion, Inc., stated, "The third quarter marked a number of accomplishments and we are on track with our 2015 milestone plan. The submission of our second-generation OVA1® test, Overa®, continues to progress with the FDA. On the commercial front in the US, we now have positive medical policy with CareFirst Blue... More